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Cellular immunity is critical for protection against tuberculosis, but its integrity is compromised during undernutrition. The
present study was designed to evaluate if the attenuated mycobacterium BCG is a safe vaccine for undernourished individuals.
An experimental model of undernutrition was established by subjecting BALB/c mice to dietary restriction. These animals
received 70% of the amount of food consumed by the healthy control group and exhibited physiological alterations compatible
with malnutrition, including body weight loss, reduced levels of triglycerides and glucose, and reduced lymphocyte numbers.
Undernourished mice were immunized with BCG, and the mycobacterial loads in lymph nodes, spleen, liver, lungs, and thymus
were determined. A much higher proportion of undernourished mice exhibited bacterial dissemination to the lymph nodes,
spleen and liver. In addition, only undernourished animals had bacteria in the lungs and thymus. Concomitant with higher
mycobacterial loads and more widespread BCG dissemination in undernourished mice, production of TNF-α, IFN-γ, and IL-
10 was also diminished in these mice. Taken together, these results indicate that BCG infection is more severe in undernourished
mice. Whether a similar phenomenon exists in undernourished children or not remains to be thoroughly investigated.
1. Introduction
Undernutrition is one of the major causes of mortality and
morbidity worldwide. Latest estimates indicate that over
800 million people in the world are undernourished [1].
Poverty and lack of adequate sanitary conditions contribute
to a higher prevalence of malnutrition in underdeveloped
countries. Protein-energy malnutrition (PEM) is the most
common type of undernutrition and is caused by deficiencies
in protein or macro- and micronutrients such as vitamin
A, vitamin E, vitamin B6, folate, zinc, iron, copper, and
selenium [2]. Inadequate energy intake leads to various phys-
iological deficiencies, such as growth deficiencies and loss
of fat, muscle and visceral mass, and has deleterious eﬀects
on the immune system [3]. Undernutrition has been linked
to many deficiencies of the innate immunity as decreased
lysozyme production by monocytes and polymorphonuclear
cells (PMNs), depletion of complement components, and
impairment of macrophage functions [4]. Adaptive immu-
nity is also compromised during nutritional depletion. PEM
impairs, for example, cytokine production, T-cell function,
and the ability of lymphocytes to appropriately respond to
these cytokines [5].
The most immediate consequence of undernutrition is
increased susceptibility to infections. Tuberculosis (TB) is a
disease caused by Mycobacterium tuberculosis that has histor-
ically been known to be influenced by undernutrition. It is
the major cause of morbidity and mortality in developing
countries where malnutrition is also prevalent [6]. It is also
well established that the cellular immune response, whose
eﬃcacy is compromised during undernutrition, is required
to protect against TB. The only available vaccine against
TB is the attenuated Mycobacterium bovis Bacillus Calmette-
Gue´rin (BCG) that is recommended by the World Health
Organization for all infants under one year of age. Around
100 million newborn children are given this vaccine, and
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the global vaccine coverage is estimated to be 80% [7].
Regardless, large numbers of well-documented trials show
extensive variation in the protective eﬃcacy of BCG, ranging
from 0 to 80% [8]. Although the overall eﬃcacy is low,
most studies agree that BCG protects against disseminated
disease in newborns and children but that this immunity
wanes with age, resulting in no or insuﬃcient protection
against adult pulmonary TB [9, 10]. For this reason, there
is great interest in developing new vaccines to prevent TB
infection. A number of alternative living and nonliving
TB vaccines, including genetic vaccines, are currently being
investigated [11–13]. For example, DNAhsp65 is a genetic
vaccine containing the gene of mycobacterial 65 kDa heat
shock protein that has also been used in prime-boost
protocols as an attempt to improve BCG eﬃcacy. Safe and
eﬀective heterologous prime-boost regimens that augment
BCG or recombinant BCG immunization are considered
the most realistic strategies for TB control [10]. We pre-
viously reported that both DNAhsp65 and BCG could
prime newborn mice for stronger immune responses to
DNAhsp65 boosters at the adult stage [13]. Prime-boost
strategies combining these two vaccines were also able to
protect well-nourished mice and guinea pigs against TB
infection [14, 15]. More recently, we demonstrated that the
antibody induction by the same genetic vaccine (DNAhsp65)
was abrogated in animals submitted to dietary restriction
[16]. We also observed that immunization with formalized
Staphylococcus aureus protected well-nourished mice but
not undernourished ones from lung injury in methicilin-
resistant S. aureus infection [17].
The present study was designed to compare BCG dissem-
ination and load between well-nourished and undernour-
ished mice.
2. Materials andMethods
2.1. Animals. Four- to five-week-old isogenic female BALB/c
mice were housed in plastic cages with white wood chips
for bedding, free access to filtered water, and conditions of
controlled lighting (12 h light/12 h dark cycle) and temper-
ature (23 ± 2◦C). After weaning, mice were acclimated on
standard chow for 10 days (Purina, Paulı´nia, SP, Brazil).
This animal chow is considered adequate for mice and it is
oﬃcially approved by the Brazilian Ministry of Agriculture
(SP-0311730758). Animals were manipulated in compliance
with the ethical guidelines adopted by the Brazilian College
of Animal Experimentation, and the experimental protocol
used in this work was approved by the local ethics committee
(19/08-CEEA).
2.2. Experimental Design. We initially analyzed physical,
hematological, biochemical, and immunological parameters
associated with 10 days of undernutrition. For this, mice
were allocated into two experimental groups: the control
group (normal) and the undernourished one (restricted).
The first one was fed ad libitum and the second one
received only 70% of the amount of food consumed by
the control group. Bacterial loads and cytokine production
were then compared in normal and undernourished mice
intradermally inoculated with BCG (105 CFU) at the base
of the tail. Immunization of the undernourished group
was delivered at the day 10 after the beginning of dietary
restriction. The evaluations were performed 25 days after the
beginning of food restriction. In the aforementioned evalua-
tions, both experimental groups were housed in a ventilated
caging system. To test the eﬀect of household contact, normal
and undernourished nonimmunized mice were also housed
in conventional open cages, in the same room of immunized
animals, before determination of bacterial loads in diﬀerent
organs.
2.3. Hematological and Biochemical Parameters. Blood sam-
ples were collected by retro-orbital puncture and directly
examined for hematological analysis or centrifuged for
sera separation. Total leukocyte numbers were determined
after blood dilution in Turk’s solution, and diﬀerential
leukocyte count was performed in blood smear stained
with eosin/methylene blue (Leishman’s stain). Blood glucose
level was measured with Prestige Smart System (Home
Diagnostics, FL, USA). Total protein, albumin, triglycerides
and cholesterol in serum samples were measured by biuret,
bromocresol green, and enzymatic Trinder standard meth-
ods, respectively (Labtest Diagno´stica SA, Belo Horizonte,
MG, Brazil).
2.4. Cytokine Production. Murine spleens were removed, dis-
rupted, and filtered in nylon cell strainers (BectonDickinson,
Franklin Lakes, NJ, USA). Splenocytes were resuspended
in RPMI 1640 medium (Cultilab, Campinas, SP, Brazil)
and then centrifuged (10min, 1500 rpm, 4◦C). Splenocytes
were resuspended in RPMI medium supplemented with
10% fetal calf serum, 2mM L-glutamine and 40mg/mL
gentamicin. Cells were plated at 5 × 106 cells/mL in 48-
well flat-bottomed culture plates (Nunc) and stimulated
with 10 μg/mL of recombinant heat shock protein 65-
kDa (rhsp65) or 10 μg/mL of concanavalin A (ConA) type
IV-S (Sigma, St. Louis, MO, USA). Cytokine levels were
evaluated 48 h later by enzyme-linked immunosorbent assay
(ELISA) in culture supernatants using IFN-γ and IL-10
BD OptEIA Sets (Becton Dickinson) and TNF-α Duoset
(R&D Systems, Minneapolis, MN, USA). The assays were
performed according to the manufacturer’s instruction.
2.5. Tissue Bacterial Loads. Thymus, inguinal and popliteal
lymph nodes, spleen, lungs, and liver from each mouse were
collected and homogenized in 1mL of saline. Next, 100 μL
of organ homogenates was plated in 7H11 mycobacteria agar
and incubated at 37◦C. After 30 days, Mycobacterium bovis
colony forming units (CFUs) were counted.
2.6. Statistical Analysis. Statistical analyses were performed
using SigmaPlot (Systat Software, CA, USA). Body weight
was analyzed by paired t-test. All experiments related to
BCG immunization were analyzed by one-way ANOVA para-
metric test or Kruskal-Wallis nonparametric test followed
by comparative Dunn’s test. Other results were analyzed by
unpaired t-test. P values < 0.05 were considered statistically
significant.
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Table 1: Physical, hematological, biochemical, and immunological
parameters in undernourished BALB/c mice. Body weight was
recorded daily and the other parameters were evaluated on day 10
after the beginning of dietary restriction. Values represent mean ±
standard deviation of 6 animals.
Parameters Normal n = 6 Restricted n = 6
Initial body weight (g) 20.66± 1.23 20.65± 1.15
Final body weight (g) 21.21± 1.16 18.68± 0.87∗
Total leucocytes (106 cells/mL) 7.70± 2.54 3.95± 0.56∗
Lymphocytes (106 cells/mL) 6.89± 2.51 3.43± 0.56∗
PMNs (106 cells/mL) 0.78± 0.30 0.51± 0.19∗
Monocytes (106 cells/mL) 0.03± 0.01 0.01± 0.03∗
Glucose (dL/mL) 68.25± 9.75 58.27± 7.23∗
Total proteins (g/dL) 6.16± 0.39 6.21± 0.19
Albumin (g/dL) 2.52± 0.18 2.62± 0.08
Triglycerides (mg/dL) 198± 54 65± 8∗
Cholesterol (mg/dL) 87± 9 82± 5
IFN-γ (pg/mL) 26181± 6589 22076± 3783
TNF-α (pg/mL) 153± 23 127± 26
IL-10 (pg/mL) 506± 96 487± 95

P ≤ 0.05 compared to initial weight.
∗P ≤ 0.05 compared to normal counterpart.
3. Results
3.1. Alterations Induced by Experimental Undernutrition.
Physical, hematological, biochemical, and immunological
alterations possibly triggered by malnutrition were deter-
mined 10 days after the beginning of dietary restriction.
At this time, body weight was already significantly lower in
comparison to the normal group. Levels of triglycerides and
glucose were also significantly below normal levels. Number
of lymphocytes, PMNs, and monocytes in the undernour-
ished group were all significantly lower than in normal
animals. By this time, the production of IFN-γ, TNF-α, and
IL-10 by spleen cells stimulated with ConA was similar in the
two experimental groups. These results are shown in Table 1.
3.2. BCG Dissemination and Load in Undernourished Mice.
Fifteen days after subcutaneous BCG immunization, normal
and undernourished mice were euthanized and bacterial
loads in secondary lymphoid organs, liver, lungs and thymus
were assessed. As expected, bacteria were not recovered
from nonimmunized animals. However, striking diﬀerences
were observed between normal and undernourished mice
immunized with BCG. A much higher proportion of under-
nourished mice exhibited bacterial dissemination to lymph
nodes, spleen, and liver, and only undernourished animals
had bacteria in the lungs and thymus. Interestingly, BCG
was recovered from undernourished but not from well-
nourished household contacts (Table 2). Levels of bacilli
recovered from lymph nodes and thymus of undernourished
animals are illustrated in Figure 1.
3.3. Eﬀect of Undernutrition and BCG on Cytokine Pro-
duction. Cytokine production was significantly aﬀected by
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Figure 1: Eﬀect of undernutrition on BCG dissemination. BALB/c
mice were submitted to 10 days of dietary restriction and then
immunized with BCG. Bacilli were recovered from the lymph nodes
and thymus 15 days after BCG immunization. CFU values represent
mean ± standard deviation of 6–10 animals.
both undernourishment and BCG immunization. Spleen
cells from undernourished mice produced less IFN-γ in
response to rhsp65 stimulation than well-nourished animals.
These cells also produced less IFN-γ after ConA addition.
In normal mice, but not in undernourished ones, BCG
immunization was associated with higher production of
IFN-γ, TNF-α, and IL-10 by spleen cells stimulated with
rhsp65 (Figure 2).
4. Discussion
Experimental dietary restriction is being used to explore the
eﬀects of PEM on immunity and susceptibility to infectious
agents [18]. However, no study to date has evaluated the
eﬀect of undernutrition on susceptibility to attenuated
vaccines that could theoretically behave as virulent path-
ogens. We first characterized the malnourished state in a
mouse model and determined its eﬀect on BCG dissemi-
nation and load. The immunological alterations triggered
by undernutrition and the eﬀect of BCG on cytokine
production in undernourished mice were also evaluated.
BCG was intradermally injected after 10 days of dietary
restriction when several changes were already evident. Body
weight, number of total leukocytes, PMNs, and lymphocytes,
and serum levels of glucose and triglycerides were all below
normal levels in undernourished animals by this time point.
Bacilli amount was determined in lymph nodes, spleen,
thymus, and liver to compare the severity of BCG infection.
The percentage of animals from which bacilli were recovered
considering all evaluated organs was always much higher
in the undernourished group. In addition, no bacteria were
able to spread to the lungs and thymus in well-nourished
mice, whereas bacilli recovery in the lungs and thymus of
undernourished ones occurred in 50% and 82% of the
animals, respectively. Another indication that BCG infection
was more severe in undernourished mice was revealed
by BCG loads in diﬀerent organs. A significantly higher
amount of bacilli was detected in the lymph nodes and
thymus of undernourished immunized mice in comparison
to their well-nourished counterparts. In contrast, there was
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Table 2: Number of colonized BALB/c mice after BCG immunization. (A) Percentage of colonization in the lymph nodes, spleen, liver, lungs
and thymus of normal immunized mice. (B) Percentage of colonization in diﬀerent organs of animals immunized with BCG after 10 days of
dietary restriction. (C) Percentage of colonization in diﬀerent organs of household contacts (nonimmunized undernourished mice housed
in conventional open cages allocated in the same room of immunized animals).
Groups Lymph nodes % Spleen % Liver % Lung % Thymus %
A Normal + BCG 7/13 54 2/6 33 1/12 8 0/7 0 0/12 0
B Restricted + BCG 10/11 91 4/5 80 5/12 42 3/6 50 9/11 82
C Undernourished household contacts 2/4 50 1/4 25 1/4 25 NS NS 0/4 0
NS = not shown.
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Figure 2: Eﬀect of undernutrition on cytokine production by BALB/c mice immunized with BCG. Splenic cells were stimulated with rhsp65
or ConA, and IFN-γ, TNF-α, and IL-10 production were measured by ELISA. Evaluations were performed 25 days after the beginning of
dietary restriction, that is, 15 days after BCG immunization. Values represent mean ± standard deviation of 6-7 animals. ∗P ≤ 0.05.
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no diﬀerence in BCG loads in the spleen, and liver of
undernourished compared to well-nourished mice (data not
shown).
An additional experiment was performed to compare the
eﬀect of household contact between healthy and undernour-
ished mice. No bacilli were recovered from well-nourished
nonimmunized mice housed in the same environment as
well-nourished BCG-immunized mice. In contrast, BCG was
detected in the lymph nodes, spleen and liver of some under-
nourished nonimmunized household contacts, as shown
in Table 2. This finding deserves further investigation and
is relevant for undernourishment in household contacts,
especially in the case of TB and attenuated viral and bacterial
vaccines. Severe malnutrition is described as an important
risk factor for the transmission of infections to children in
household contact with adults with pulmonary TB [19].
To the best of our knowledge, this is the first report
describing the eﬀect of BCG in experimental undernutrition.
Two points related to these findings deserve special atten-
tion. The first one relates to the eﬃcacy of BCG and its
potential to trigger disseminated BCG infection (BCGosis)
in undernourished children. Children with severe combined
immunodeficiency can develop BCGosis after BCG immu-
nization as a result of their deficient immune system, which
clearly illustrates that vaccinations should only be performed
in immunocompetent individuals [20]. The second point
relates to the immunological consequences of BCG presence
in the thymus of undernourished mice. Only a few reports
have analyzed mycobacterial colonization in the murine thy-
mus. Nobrega et al. reported that colonization of the thymus
by BCG was delayed and occurred at a time when bacterial
load was already decreasing in other organs [21]. Our results
showed that BCG colonized the thymus of undernourished
immunized mice at an early time point, that is, 15 days after
BCG inoculation, whereas no mycobacteria was detected in
the thymus of well-nourished mice. Future investigations
should clarify whether the presence of mycobacteria can
influence thymic selection and consequently aﬀect the course
of mycobacterial or other infectious diseases. Interestingly, a
recent report demonstrated that mycobacteria dissemination
to the thymus rendered newly generated T cells tolerant to
the invading pathogen [22].
Analysis of cytokine production 15 days after BCG im-
munization (25 days after the beginning of dietary restric-
tion) indicated that splenocytes from malnourished mice
were deficient in their ability to produce IFN-γ in response
to both specific (rhsp65) and policlonal (ConA) stimuli. In
addition, splenocytes from healthy but not undernourished
animals immunized with BCG produced significant levels of
IFN-γ, TNF-α, and IL-10 in response to in vitro stimulation
with rhsp65. This lower production of TNF-α and IFN-
γ by undernourished mice could explain the higher BCG
load in these animals, as these cytokines are known to
activate macrophages to restrain mycobacterial growth [23,
24]. Similarly, lower production of these cytokines associated
with undernutrition could facilitate BCG dissemination to
the thymus and lungs in these animals. Even though the
extent of protection aﬀorded by BCG is highly debated, the
consensus is that this vaccine is able to protect children
against more severe forms of TB infections [25] and leprosy
[26] and may also oﬀer nonspecific protection against other
infectious diseases [27]. Undernutrition could, therefore,
severely undermine all these protective eﬀects associated with
BCG.
As we mentioned before, IL-10 production was also
clearly aﬀected by undernutrition. Whereas normal mice
produced significant higher levels of this cytokine after
BCG immunization, there was no IL-10 upregulation in
undernourished mice. It is tempting to speculate that the
immunoregulatory properties of BCG in autoimmunity and
allergies are related to IL-10 production and are conse-
quently lost in undernourished individuals. Evidence of
the immunoregulatory eﬀects of BCG in healthy animals
has been described. Sewell et al. observed that Schistosoma
mansoni OVA pretreatment, BCG infection, and lyophilized
M. tuberculosis all decreased clinical manifestations of exper-
imental autoimmune encephalomyelitis in mice [28]. Inter-
estingly, this immunoregulatory activity has been associated
with IL-10 production by regulatory Th17 cells [29] and
dendritic cells [30].
5. Conclusions
Taken together, these results raise questions regarding the
safety and eﬃcacy of BCG vaccination in undernourished
children. For instance, it will be important to assess whether
these children develop BCGosis. Studies of the protective
eﬀects of BCG against leprosy and more severe forms of TB
are also essential. Finally, the potential loss of the ability of
BCG to downregulate deleterious immune responses associ-
ated with autoimmunity and allergy and the consequences
of BCG dissemination to the thymus in undernourished
individuals also deserve further investigation.
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